Epidemiological Characterization of Clostridium Difficile Strains in Shanghai, China
H. Huang,S. Wu,M. Wang,Y. Zhang,H. Fang,A. C. Palmgren,A. Weintraub,C. E. Nord
DOI: https://doi.org/10.1016/j.ijid.2008.05.1194
IF: 12.073
2008-01-01
International Journal of Infectious Diseases
Abstract:Background: Clostridium difficile remains the leading cause of nosocomial-acquired diarrhea. The number of outbreaks of Clostridium difficile-associated diarrhea (CDAD) that are severe or fulminant has risen markedly in many North American and European hospitals since 2003 despite breakthroughs in clinical diagnosis, effective treatments and infection control programs. However, there is still a paucity of epidemiological data on CDAD in China. Methods: A 1-year prospective study of C. difficile infections was conducted in Huashan hospital in order to obtain an overview of the phenotypic and genotypic features of clinical isolates of C. difficile. Results: Of 58 isolates from diarrhoeagenic patients with suspected CDAD, 46 were toxigenic: 36 were positive for both toxins A and B, and 10 were toxin A-negative toxin B-positive. All strains were binary toxin negative. The minimum inhibitory concentrations of 12 antimicrobial agents were determined using the agar dilution method. All strains were fully susceptible to metronidazole, vancomycin, meropenem and piperacillin/tazobactam. Resistance to moxifloxacin, ciprofloxacin, levofloxacin, erythromycin, clindamycin, tetracycline, rifampin, fusidic acid was found in 41.4%, 100%, 50%, 72.4%, 72.4%, 34.5%, 24.1% and 6.9% of the isolates, respectively. Co-resistance to erythromycin, tetracycline and moxifloxacin was found in 12 strains. Resistance to moxifloxacin or tetracycline was associated with resistance to erythromycin. Ten different ribotypes were identified by PCR, with four ribotypes (SH I, SH II, SH III and SH IV) accounting for 66.7% of the strains. None of them was the same as the strain BI/NAP/027. Conclusion: The present study is the first China survey of C. difficile isolates from patients with CDAD. Ongoing epidemiological surveillance of cases of CDAD is required to detect clustering of cases and to monitor the emergence of specific highly virulent clones in China.